Administration of a long term release GnRH superagonist during the canine postnatal critical window

FAYA, M.; MARCHETTI, C.; PRIOTTO, M.; GRISOLÍA ROMERO, M.; ZURBRIGGEN, G.; GRAIFF, D.; GOBELLO, C.

Boston

Simposio; 6th International Symposium on Non-Surgical Contraceptive Methods of Pet Population Control; 2018

Alliance for Contraception in Cats & Dogs

The objective of this study was to assess the efficiency and clinical safety of postnatal administration of a GnRH agonist on canine puberty postponement. Sexual steroids and histological gonadal changes were also described. Twenty-four littermate puppies were randomly assigned to: Deslorelin acetate 18.8 mg sc (DESLO; n = 12) or Placebo: sc (PLACE; n = 12) postnatally. The dogs were clinically and endocrinologically followed up until puberty when they were gonadectomized and their gonads histomorphometrically studied. Deslorelin postponed the age of puberty (72.7 ± 4.8 vs. 35.8 ± 1.9 weeks; P  0.1) independently of their group and pubertal status. None of the females had side effects while the 2 non pubertal DESLO males presented bilateral cryptorchydism. All the bitches ovulated at puberty (P > 0.1) and the 2 DESLO that were mated became pregnant. Deslorelin postponed basal serum sexual steroids up to puberty in both genders (P